GB899059A - Improvements in or relating to therapeutic compositions containing a pyridine derivative - Google Patents
Improvements in or relating to therapeutic compositions containing a pyridine derivativeInfo
- Publication number
- GB899059A GB899059A GB35115/60A GB3511560A GB899059A GB 899059 A GB899059 A GB 899059A GB 35115/60 A GB35115/60 A GB 35115/60A GB 3511560 A GB3511560 A GB 3511560A GB 899059 A GB899059 A GB 899059A
- Authority
- GB
- United Kingdom
- Prior art keywords
- oral
- relating
- humans
- powders
- compositions containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A therapeutic preparation for oral or topical use in the treatment of trichomonal infections in humans and cattle comprises as essential ingredient (A) thereof 2-hydroxy-5-nitro-pyridine <FORM:0899059/VI/1> oral preparations may be in the form of tablets, pills, capsules and powders. Topical preparations may be in the form of ointments, lotions, pastes, jellies, powders and vaginal suppositories. Anti-oxidants, preservatives, buffers and perfumes may be present. Optional ingredients are (a) antibiotics, e.g. tetracycline phosphate complex and (b) sulphonamides, e.g. sulphamethylthiadiazole. Topical preparations contain 0.5 to 5% of (A). The oral single dosage unit contains 50 to 1000 mg. of (A) and the vaginal tablet or suppository 50 to 250 mg. of (A). The dose for animals is 10 times that for humans. Specification 794,482 is referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85551159A | 1959-11-27 | 1959-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB899059A true GB899059A (en) | 1962-06-20 |
Family
ID=25321433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB35115/60A Expired GB899059A (en) | 1959-11-27 | 1960-10-13 | Improvements in or relating to therapeutic compositions containing a pyridine derivative |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE597506A (en) |
FR (1) | FR836M (en) |
GB (1) | GB899059A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6598371B1 (en) | 1998-10-06 | 2003-07-29 | Stanelco Fibre Optics Ltd. | Capsules |
WO2007060690A1 (en) * | 2005-11-22 | 2007-05-31 | Subramanyam Sundaresan | A preparation for enhancing yield in agriculture and horticulture |
-
1960
- 1960-10-13 GB GB35115/60A patent/GB899059A/en not_active Expired
- 1960-11-25 BE BE597506A patent/BE597506A/en unknown
- 1960-11-26 FR FR845125A patent/FR836M/fr active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6598371B1 (en) | 1998-10-06 | 2003-07-29 | Stanelco Fibre Optics Ltd. | Capsules |
WO2007060690A1 (en) * | 2005-11-22 | 2007-05-31 | Subramanyam Sundaresan | A preparation for enhancing yield in agriculture and horticulture |
Also Published As
Publication number | Publication date |
---|---|
FR836M (en) | 1961-10-02 |
BE597506A (en) | 1961-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB931946A (en) | Production of tablets of pharmaceutical and other chemical compositions | |
GB899059A (en) | Improvements in or relating to therapeutic compositions containing a pyridine derivative | |
GB1049996A (en) | New medicine with anti-inflammatory and anti-rheumatic activity | |
ES294897A1 (en) | Improvements introduced in the preparation of pharmaceutical compositions in the form of unit dose (Machine-translation by Google Translate, not legally binding) | |
GB976096A (en) | Pharmaceutical compositions | |
GB1292496A (en) | Dosage units of contraceptive preparations for human use | |
GB1072359A (en) | Pyrazolone derivatives and pharmaceutical compositions containing them | |
GB858455A (en) | Piperazine preparations for treatment of worm infections | |
GB1125924A (en) | Organic bismuth derivative | |
GB1001314A (en) | Pharmaceutical preparations for combating parasitic helminths | |
GB911179A (en) | Hypnotic and tranquilizing compositions comprising 4, 6-dimethyl-3-pyridazone | |
AU414340B2 (en) | Medicinal compositions for administration to animals and process for administering same | |
AU3469468A (en) | Medicinal compositions for administration to animals and process for administering same | |
Reiches | Angular stomatitis treated with silicote ointment | |
AU268742B2 (en) | 1,2,3,4,5,7-HEXAHYDRO-11b-H-BENZOPYRIDOCOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
GB1029050A (en) | Improvements in and relating to new flavone and the process of preparation and application thereof | |
AU1790762A (en) | 1,2,3,4,5,7-HEXAHYDRO-11b-H-BENZOPYRIDOCOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
AU260990B2 (en) | Pharmacologically active 2-thenyl-guanidine derivatives, their preparation, and pharmaceutical compositions thereof | |
AU275110B2 (en) | 5, 8-dimithoxy-4-methyl-6, 7-furano-coumarin compounds, process for their preparation and pharmaceutical compositions containing same | |
GB1269616A (en) | Improvements in pharmaceutical compositions | |
GB709088A (en) | Anti-bacterial therapeutic preparations containing penicillin | |
GB901617A (en) | Oral compositions for promoting skin-pigmentation | |
AU1643662A (en) | Pharmacologically active 2-thenyl-guanidine derivatives, their preparation, and pharmaceutical compositions thereof | |
AU2550062A (en) | 5, 8-dimithoxy-4-methyl-6, 7-furano-coumarin compounds, process for their preparation and pharmaceutical compositions containing same | |
GB949434A (en) | Therapeutic antibacterial compositions comprising antibiotics |